PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmjLink to Publisher's site
 
BMJ. 1990 January 6; 300(6716): 18–22.
PMCID: PMC1661869

Single dose cefotaxime plus metronidazole versus three dose cefuroxime plus metronidazole as prophylaxis against wound infection in colorectal surgery: multicentre prospective randomised study.

Abstract

OBJECTIVE--To establish whether a single preoperative dose of cefotaxime plus metronidazole was as effective as a standard three dose regimen of cefuroxime plus metronidazole in preventing wound infection after colorectal surgery. DESIGN--Prospective randomised allocation to one of two prophylactic antibiotic regimens in a parallel group trial. Group sequential analyses of each 250 patients were performed. SETTING--14 District general and teaching hospitals. PATIENTS--1018 Adults having colorectal operations were randomised, of whom 943 were evaluated. Demographic features, conditions requiring surgery, and operative procedures were similar in the two groups. Most patients had surgery for carcinoma of the colon or rectum. INTERVENTIONS--Group 1 received cefotaxime 1 g intravenously plus metronidazole 500 mg intravenously preoperatively. Group 2 received cefuroxime 1.5 g intravenously plus metronidazole 500 mg intravenously preoperatively, followed by cefuroxime 750 mg intravenously plus metronidazole 500 mg intravenously eight hours and 16 hours postoperatively. MAIN OUTCOME MEASURES--Development of surgical wound infection (as evidenced by the presence of pus), death, or discharge from hospital. RESULTS--Wound condition was scored on a five point scale on alternate days until discharge or for up to 20 days postoperatively. Wound infection rates were: group 1, 32/453 (7.1%; 95% confidence interval 4.7% to 9.4%); group 2, 33/454 (7.3%; 95% confidence interval 4.9% to 9.6%). Death rates (group 1: 26/470 (5.5%); group 2: 31/471 (6.6%], the incidence of postoperative complications, the median duration of hospital stay (12 days), and antibiotic tolerance were all similar in the two groups. Pooled data from groups 1 and 2 showed that wound infections were more frequent when minor faecal contamination had occurred at operation and when the duration of operation exceeded 90 minutes (greater than 90 min 11.2% of cases; less than 90 min 4.8%) and were associated with an extended hospital stay. CONCLUSIONS--A single preoperative dose of cefotaxime plus metronidazole is an efficacious as a three dose regimen of cefuroxime plus metronidazole in preventing wound infection after colorectal surgery and has practical advantages in eliminating the need for postoperative antibiotics.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Eykyn SJ, Jackson BT, Lockhart-Mummery HE, Phillips I. Prophylactic peroperative intravenous metronidazole in elective colorectal surgery. Lancet. 1979 Oct 13;2(8146):761–764. [PubMed]
  • Keighley MR, Arabi Y, Alexander-Williams J, Youngs D, Burdon DW. Comparison between systemic and oral antimicrobial prophylaxis in colorectal surgery. Lancet. 1979 Apr 28;1(8122):894–897. [PubMed]
  • Danziger L, Hassan E. Antimicrobial prophylaxis of gastrointestinal surgical procedures and treatment of intraabdominal infections. Drug Intell Clin Pharm. 1987 May;21(5):406–416. [PubMed]
  • Fry DE. Antibiotics in surgery. An overview. Am J Surg. 1988 May 31;155(5A):11–15. [PubMed]
  • Haddock G, Hansell DT, McArdle CS. Survey of antibiotic prophylaxis in gastrointestinal surgery in Scotland--5 years on. J Hosp Infect. 1988 Apr;11(3):286–289. [PubMed]
  • Stubbs RS, Griggs NJ, Kelleher JP, Dickinson IK, Moat N, Rimmer DM. Single dose mezlocillin versus three dose cefuroxime plus metronidazole for the prophylaxis of wound infection after large bowel surgery. J Hosp Infect. 1987 May;9(3):285–290. [PubMed]
  • Mittermayer H, Gross C, Brücke P. Single dose cefuroxime/metronidazole versus metronidazole alone in elective colorectal surgery. Am Surg. 1984 Aug;50(8):418–423. [PubMed]
  • Cunliffe WJ, Carr N, Schofield PF. Prophylactic metronidazole with and without cefuroxime in elective colorectal surgery. A prospective randomised double-blind study. J R Coll Surg Edinb. 1985 Apr;30(2):123–125. [PubMed]
  • Colizza S, De Fazio S, Addari A, Grande R, Cucchiara G. Short-term prophylaxis with cefuroxime in colorectal surgery for cancer. J Surg Oncol. 1987 Aug;35(4):266–268. [PubMed]
  • Jagelman DG, Fabian TC, Nichols RL, Stone HH, Wilson SE, Zellner SR. Single-dose cefotetan versus multiple-dose cefoxitin as prophylaxis in colorectal surgery. Am J Surg. 1988 May 31;155(5A):71–76. [PubMed]
  • Burdon DW, Keighley MR. Ceftriaxone and metronidazole as single-dose prophylaxis in colorectal surgery. S Afr Med J. 1987 Jun 20;Suppl 2:15–18. [PubMed]
  • Kingston RD, Kiff RS, Duthie JS, Walsh S, Spicer A, Jeacock J. Comparison of two prophylactic single-dose intravenous antibiotic regimes in the treatment of patients undergoing elective colorectal surgery in a district general hospital. J R Coll Surg Edinb. 1989 Aug;34(4):208–211. [PubMed]
  • DiPiro JT, Welage LS, Levine BA, Wing PE, Stanfield JA, Gaskill HV, Scarfoni DS, Schentag JJ, Bowden TA, Jr, Williams JS. Single-dose cefmetazole versus multiple dose cefoxitin for prophylaxis in abdominal surgery. J Antimicrob Chemother. 1989 Apr;23 (Suppl 500):71–77. [PubMed]
  • Jones RN, Wojeski WV. Single-dose surgical prophylaxis using ticarcillin/clavulanic acid (Timentin): a prospective, randomized comparison with cefotaxime. Diagn Microbiol Infect Dis. 1987 Jul;7(3):219–223. [PubMed]
  • Rowe-Jones DC, Cole DS. Single dose mezlocillin versus three dose cefuroxime plus metronidazole for prophylaxis in large bowel surgery. J Hosp Infect. 1988 Aug;12(2):131–132. [PubMed]
  • Diamond T, Mulholland CK, Hanna WA, Parks TG. A prospective randomized trial to compare triple dose mezlocillin with triple dose cefuroxime plus metronidazole as prophylaxis in colorectal surgery. J Hosp Infect. 1988 Oct;12(3):215–219. [PubMed]
  • Cann KJ, Watkins RM, George C, Payne-James J, Crawfurd E, Rogers TR. A trial of mezlocillin versus cefuroxime with or without metronidazole for the prevention of wound sepsis after biliary and gastrointestinal surgery. J Hosp Infect. 1988 Oct;12(3):207–214. [PubMed]
  • Whitehead J, Stratton I. Group sequential clinical trials with triangular continuation regions. Biometrics. 1983 Mar;39(1):227–236. [PubMed]
  • Donowitz GR, Mandell GL. Drug therapy. Beta-lactam antibiotics (2). N Engl J Med. 1988 Feb 25;318(8):490–500. [PubMed]
  • Kingston RD, Duthie J. Serious postoperative bleeding associated with a single intravenous dose of cefuroxime and metronidazole. J Hosp Infect. 1986 Jan;7(1):100–101. [PubMed]
  • Fuchs PC, Jones RN, Barry AL, Allen SD, Ayers LW, Pfaller M. Desacetylcefotaxime--another broad spectrum cephalosporin? J Antimicrob Chemother. 1989 Jan;23(1):165–167. [PubMed]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Group